PCSK9 Inhibitor Therapy as an Alternative for Statin Intolerance

• Main Authors: K. O. Shnaider (Author), M. L. Maximov (Author), V. A. Baranova (Author), A. A. Nekipelova (Author)
• Format: Book
• Published: Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products», 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Scientific relevance. The main cause of cardiovascular pathologies is atherosclerosis, which is secondary to lipid metabolism disorders, in particular, the accumulation of low-density lipoprotein (LDL) cholesterol. Dyslipidaemia treatment with the largest evidence base predominantly includes statins...